Product Description
Overall, the global ERCP device market was valued at over $1.9 billion in 2025. This is expected to increase over the forecast period at a CAGR of 5.6% to reach over $2.8 billion.
The full report suite on the global market for endoscopic retrograde cholangiopancreatography (ERCP) devices includes sphincterotomes, biliary stone removal balloons, biliary stone removal baskets, biliary dilation balloons, biliary and pancreatic stents, biliary lithotripters, ERCP guidewires and ERCP cannulas.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Endoscopic Retrograde Cholangiopancreatography Market Trends
There is a continuing shift toward therapeutic ERCP, which is driving increased demand for sphincterotomes. As one of the largest segments within the ERCP device market, growth in sphincterotome sales is a key driver supporting overall expansion of the ERCP device market.
Endoscopic Retrograde Cholangiopancreatography Market Share Insights
- Boston Scientific led the global ERCP device market in 2025, holding about half of the total market share. The company’s strong position was driven by the success of its AXIOS™ lumen-apposing covered-metal stent, acquired through its 2015 purchase of Xlumena. The AXIOS™ device, used for transgastric or transduodenal endoscopic drainage of pancreatic pseudocysts and walled-off necrosis, has become a key innovation in the ERCP space. Beyond stents, Boston Scientific also maintained leading positions in guidewires, with its Jagwire® short-wire system widely adopted by endoscopists.
- Olympus was the second-largest competitor in the ERCP device market in 2025, with strong performance in the biliary lithotripter and guidewire segments. The company’s V-System™, a short-wire platform compatible with all Olympus accessory devices, has been instrumental to its success. As market demand continues to shift toward short-wire systems, Olympus is well positioned to expand its share in the sphincterotome segment and strengthen its overall competitive position.
- Cook Medical ranked third in the global ERCP device market in 2025. The company held the second-largest share in North America and ranked third in both Western Europe and other regions. Cook Medical’s extensive product portfolio spans nearly all ERCP device categories, supporting its strong competitive standing. Continued growth is expected in the sphincterotome and guidewire segments, where the company maintains notable shares.
Endoscopic Retrograde Cholangiopancreatography Market Segmentation Summary
- Sphincterotome Market
- Biliary Stone Removal Balloon Market
- Biliary Stone Removal Basket Market
- Biliary Dilation Balloon Market
- Biliary and Pancreatic Stent Market – Further Segmented Into:
- Material Type: Covered-metal, bare-metal, and plastic.
- Biliary Lithotripter Market
- ERCP Guidewire Market
- ERCP Cannula Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
